Columbia's Zuckerman Institute
Columbia's Zuckerman Institute is a non-profit neuroscience research institute within Columbia University that operates six shared Scientific Platforms (imaging, MRI, genetic tools, virology, computing, instrumentation) and more than 50 principal investigator labs studying brain function, disease, and cognition, funded by philanthropy and federal grants.
- Company typePrivate
- Founded2025
- HeadquartersNew York, United States
- Headcount501–1,000
- GTM typeB2B
- OfferingServices
What Columbia's Zuckerman Institute does
Columbia's Zuckerman Institute, formally the Mortimer B. Zuckerman Mind Brain Behavior Institute, is a non-profit interdisciplinary neuroscience research institute operating within Columbia University in New York City. Founded in 2012 and headquartered at the Jerome L. Greene Science Center in Manhattan's Manhattanville neighborhood, it brings together more than 50 principal investigators across neuroscience, psychology, theory, and engineering — including Nobel laureate Eric Kandel and Kavli Prize winners — to study how the brain develops, performs, endures, and recovers. The institute organizes its research around thematic areas (Computation, Decision Making, Disease, Evolution, Growth & Development, Learning & Memory, Movement, The Senses, and Tools & Technology) and operates six shared Scientific Platforms that provide custom-built research infrastructure: Advanced Instrumentation (custom engineering of unavailable devices), Cellular Imaging (sheet-of-light microscopy), Custom Genetic Access Services (selective brain cell manipulation tools), Magnetic Resonance Imaging (three MRI devices for human and animal brains), Research Computing (high-performance compute and storage), and Virology (viral vectors for neural mapping).
The institute does not sell commercial products. Its revenue model is built on philanthropy (transformational gifts from Mortimer B. Zuckerman, the Jerome L. Greene Foundation, and Alan Kanzer) and competitive grants from federal agencies (NIH, NSF, BRAIN Initiative, Cancer Grand Challenges) and private foundations (Simons, Kavli, Gatsby, Swartz, HHMI). In 2024-2025, the institute secured multi-million-dollar awards including a $25 million Cancer Grand Challenges grant, an $18.3 million BRAIN Initiative award, and a $10 million Alan Kanzer gift that funded a new interdisciplinary cognition center. The institute also runs public-facing programs — including the Stavros Niarchos Foundation Brain Insight Lectures, BioBus mobile labs reaching over 30,000 students annually, the BRAINYAC high school internship, and artist/writer residencies — that serve scientific, educational, and community audiences. In 2025, leadership transitioned with Rui Costa appointed Director and CEO alongside Daphna Shohamy, who leads the new Alan Kanzer Center for Cognition and Reasoning.
Columbia's Zuckerman Institute firmographics
Firmographics- Name
- Columbia's Zuckerman Institute
- Legal name
- Columbia University in the City of New York
- Website
- https://zuckermaninstitute.columbia.edu
- Company type
- Private
- Founded year
- 2025
- Operating status
- Operating
- Headcount range
- 501–1,000 employees
- Short description
- Columbia's Zuckerman Institute is a non-profit neuroscience research institute within Columbia University that operates six shared Scientific Platforms (imaging, MRI, genetic tools, virology, computing, instrumentation) and more than 50 principal investigator labs studying brain function, disease, and cognition, funded by philanthropy and federal grants.
- Ownership category
- akta.pro rank
Columbia's Zuckerman Institute industry classification
Industry- Product category
- Neuroscience Research
- NAICS
- Research and Development in the Physical, Engineering, and Life Sciences (54171), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- General Neurology (HLAKAIAA)
- akta.pro secondary industries
- Neurogenetics & Rare Neurologic Diseases (HLAKAIAO), Neurology & Psychiatry (CNS) Pharmaceuticals (HLAIAAAF)
Keywords
Where Columbia's Zuckerman Institute is headquartered
LocationHeadquarters
- HQ city
- New York
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
Columbia's Zuckerman Institute business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Operations, Infrastructure
Revenue model
- Research Funding and Philanthropy: The institute relies on transformational gifts from donors like Dawn M. Greene and the Jerome L. Greene Foundation, and Mortimer B. Zuckerman, as well as grants from organizations like the National Institutes of Health, Simons Foundation, and other funding bodies to support neuroscience research.
Go-to-market motion1 record
Distribution channels3 records
Marketing channels5 records
Columbia's Zuckerman Institute product offering
Product offeringCore offering
Columbia's Zuckerman Institute (Mortimer B. Zuckerman Mind Brain Behavior Institute) is a nonprofit neuroscience research institute within Columbia University that conducts interdisciplinary research into brain function, development, disease, and recovery. It operates six Scientific Platforms (Advanced Instrumentation, Cellular Imaging, Custom Genetic Access Services, MRI, Research Computing, and Virology) that provide specialized tools, facilities, and expertise to faculty and research labs, and runs educational outreach programs such as the Education Lab, BioBus partnership, and BRAINYAC.
Product overview
Columbia's Zuckerman Institute is a neuroscience research institute (not a traditional product company) that operates a platform of six Scientific Platforms providing specialized research tools and services: Advanced Instrumentation (custom engineering solutions), Cellular Imaging (microscopy and imaging technologies), Custom Genetic Access Services (genetic/molecular tools), Magnetic Resonance Imaging (MRI brain imaging), Research Computing (high-performance computing infrastructure), and Virology (viral vector tools for neuroscience). Additionally, the Alan Kanzer Center for Cognition and Reasoning (launched 2025) supports interdisciplinary cognition research. Education programs include BioBus partnership and BRAINYAC. The Institute conducts fundamental neuroscience research rather than commercializing products.
Differentiator
Problem solved
Functional benefit
Brands
- Alan Kanzer Center for Cognition and Reasoning: A new dynamic interdisciplinary research initiative dedicated to understanding the biological basis of cognition, launched in 2025
- BioBus
- Alan Kanzer Artist-in-Residence Program
- Zuckerman Institute Jazz Artist-in-Residence Program
- Alan Kanzer Writer-in-Residence Program
- Alan Kanzer Postdoctoral Fellowship Program
Products and services
- Advanced Instrumentation Platform Team of electrical, mechanical, and optical engineering experts that designs, builds, and tests commercially unavailable instruments, equipment, and software for neuroscience research, supported by machine and fabrication shops, metrology and optics labs, and workshops.
Quantifiable outcome
- Transformative discoveries in understanding brain function, memory, decision-making, and disease mechanisms
- +1 more outcomes
Companies that use Columbia's Zuckerman Institute
Customer profileSegments3 records
Ideal customer profiles3 records
Columbia's Zuckerman Institute technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature6 records
Columbia's Zuckerman Institute partnerships and signals
Strategic signalPartnerships
Twelve partnerships are on record, tiered core and secondary.
- BioBuscoreNonprofit partnership supporting programs in the Education Lab and schools throughout New York. BioBus provides mobile labs reaching more than 30,000 students each year through hands-on science at schools, afterschool programs, and internships.
- International Brain LaboratorycoreInternational collaboration analyzing brain activity across multiple brain regions in mice. The consortium involves recording neurons from 43 regions across the mouse cortex at the single neuron level.
- Center for Theoretical NeurosciencecorePart of Columbia University focused on theoretical and computational approaches to understanding brain function.
- Columbia Translational Neuroscience InitiativecoreInitiative bridging neuroscience research and clinical applications.
- Kavli Institute for Brain SciencecoreCollaborative institute focused on brain science at Columbia University, co-directed by Daphna Shohamy.
- Data Science InstitutesecondaryColumbia University institute providing data science expertise and resources for neuroscience research.
- Grossman Center for the Statistics of MindcoreCenter focused on statistical approaches to understanding brain function and behavior.
- NeuroTechnology CentersecondaryCenter developing and applying new neurotechnologies for brain research.
- Motor Neuron CentersecondaryFocused on understanding and treating motor neuron diseases.
- Columbia Precision Medicine InitiativesecondaryInitiative advancing precision medicine approaches at Columbia.
- Taub Institute for Research on Alzheimer's Disease and the Aging BraincoreResearch institute focused on Alzheimer's disease and aging brain research.
- Columbia Nano InitiativesecondaryInitiative advancing nanotechnology research with applications in neuroscience.
Scale indicators4 records
Recent moves7 records
Expansion highlights6 records
Columbia's Zuckerman Institute competitors and assessment
Company assessmentRegional players
- Champalimaud Foundation (Centre for the Unknown): Lisbon-based research center with a strong neuroscience and systems neuroscience program. Operates as a comparable interdisciplinary research institute but serves a different geography.
Direct peers
- Allen Institute for Brain Science: A large nonprofit neuroscience research organization that conducts large-scale brain science research with significant philanthropic funding. Directly comparable to Zuckerman in mission, scale, and scientific platforms (imaging, genetic tools, computing).
- Salk Institute for Biological Studies: An independent nonprofit biological research institute with substantial neuroscience research alongside other biological disciplines. Comparable scale, talent base, and research-only operating model.
- Max Planck Institute for Brain Research: Leading European neuroscience research institute focused on neural circuits, computation, and behavior. Strong peer in scientific mission, faculty-led model, and tool/instrument development.
- Janelia Research Campus (HHMI): Howard Hughes Medical Institute's research campus focused on neuroscience, imaging, and tool development. Closely comparable to Zuckerman's Scientific Platforms approach and its basic-research, technology-innovation mandate.
- Picower Institute for Learning and Memory (MIT): MIT-based research institute focused on learning and memory with multidisciplinary systems neuroscience. Strong functional overlap with Zuckerman's cognition, learning, and memory research themes.
- Gladstone Institutes: A nonprofit biomedical research organization affiliated with UCSF that conducts neuroscience and disease-focused research. Comparable in its basic-research nonprofit structure and translational aspirations.
- McGovern Institute for Brain Research (MIT): MIT-based interdisciplinary brain research institute with similar structure, faculty model, and focus on tools, imaging, and understanding brain function. A direct academic peer.
Others
- Columbia University Department of Neuroscience: The broader Columbia academic department that overlaps heavily with Zuckerman in faculty, training programs, and seminar infrastructure. Not a competitor so much as a parent academic unit and training pipeline.
Broad incumbents
- Broad Institute of MIT and Harvard: A larger, broader biomedical and genomic research institute with significant neuroscience activity. While not exclusively neuroscience, it competes for the same large federal grants and computational neuroscience talent.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks5 records
Key highlights6 records
Customer concentration
Columbia's Zuckerman Institute social profiles
Digital presenceColumbia's Zuckerman Institute financial estimates
Financial estimateRevenue estimate
Valuation estimate
Columbia's Zuckerman Institute leadership team
Management profileNumber of profiles
Profiles7 records
Columbia's Zuckerman Institute subsidiaries and ownership
Company hierarchySubsidiaries1 record
Columbia's Zuckerman Institute funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Columbia's Zuckerman Institute M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Columbia's Zuckerman Institute
What does Columbia's Zuckerman Institute do?
Columbia's Zuckerman Institute (Mortimer B. Zuckerman Mind Brain Behavior Institute) is a nonprofit neuroscience research institute within Columbia University that conducts interdisciplinary research into brain function, development, disease, and recovery. It operates six Scientific Platforms (Advanced Instrumentation, Cellular Imaging, Custom Genetic Access Services, MRI, Research Computing, and Virology) that provide specialized tools, facilities, and expertise to faculty and research labs, and runs educational outreach programs such as the Education Lab, BioBus partnership, and BRAINYAC.
Is Columbia's Zuckerman Institute a public or private company?
Columbia's Zuckerman Institute is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was Columbia's Zuckerman Institute founded?
Columbia's Zuckerman Institute was founded in 2025. It employs 501 to 1,000 people.
Where is Columbia's Zuckerman Institute based?
Columbia's Zuckerman Institute is headquartered in New York, United States, in the North America region.
How does Columbia's Zuckerman Institute make money?
One revenue line is on record: research Funding and Philanthropy.
Who are Columbia's Zuckerman Institute's main competitors?
Champalimaud Foundation (Centre for the Unknown) is listed as a regional player. Direct peers are Allen Institute for Brain Science, Salk Institute for Biological Studies, Max Planck Institute for Brain Research, Janelia Research Campus (HHMI), Picower Institute for Learning and Memory (MIT), Gladstone Institutes and McGovern Institute for Brain Research (MIT). Columbia University Department of Neuroscience is listed as an others. Broad Institute of MIT and Harvard is listed as a broad incumbent.
Does Columbia's Zuckerman Institute have an API?
No public API is recorded for Columbia's Zuckerman Institute.
What industry is Columbia's Zuckerman Institute in?
Columbia's Zuckerman Institute's product category is Neuroscience Research. Its primary akta.pro industry code is HLAKAIAA, General Neurology, with a secondary code of HLAKAIAO, Neurogenetics & Rare Neurologic Diseases. Its NAICS code is 54171 and its SIC code is 8731.